EPG Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.1K | Sell |
809
-182
| -18% | -$15.1K | 0.02% | 213 |
|
|
2025
Q1 | $80.4K | Buy |
991
+75
| +8% | +$6.08K | 0.02% | 262 |
|
|
2024
Q4 | $82.5K | Buy |
916
+250
| +38% | +$22.5K | 0.02% | 267 |
|
|
2024
Q3 | $65.8K | Buy |
+666
| New | +$65.8K | 0.02% | 284 |
|
|
2024
Q2 | – | Sell |
-666
| Closed | -$63.2K | – | 304 |
|
|
2024
Q1 | $63.2K | Hold |
666
| – | – | 0.02% | 305 |
|
|
2023
Q4 | $59.1K | Buy |
666
+206
| +45% | +$18.3K | 0.02% | 296 |
|
|
2023
Q3 | $33.6K | Buy |
460
+278
| +153% | +$20.3K | 0.01% | 316 |
|
|
2023
Q2 | $15.2K | Buy |
+182
| New | +$15.2K | ﹤0.01% | 340 |
|
|
2022
Q1 | – | Sell |
-261
| Closed | -$29K | – | 440 |
|
|
2021
Q4 | $29K | Hold |
261
| – | – | 0.01% | 322 |
|
|
2021
Q3 | $33K | Buy |
+261
| New | +$33K | 0.01% | 292 |
|
|
2020
Q2 | – | Sell |
-101
| Closed | -$8K | – | 792 |
|
|
2020
Q1 | $8K | Hold |
101
| – | – | 0.01% | 526 |
|
|
2019
Q4 | $10K | Buy |
+101
| New | +$10K | 0.01% | 432 |
|